Inputs: momentum, trendVelocity
Momentum 76/100 confirmed by trend velocity 67/100.
Prediction result · Ensemble engineUpdated 5:04 AM
KMTSKestra Medical Technologies, Ltd. stock price outlook
$29.69-3.01% since prev closeNeutral
Kestra Medical Technologies, Ltd. (KMTS) is trading at $29.69, down 3.01% since the previous close and +3.23% over the past week. Price sits above its 50-day average by 11.23%, with price momentum at 76/100 and trend velocity at 67/100. Sentiment across 6 recent headlines reads net constructive at 58/100. Volatility risk is elevated (93/100) and the stock is 90% of the way up its 52-week range. The weighted factor score lands at 69/100 — a neutral signal. Research only, not investment advice.
Universal leanmarket
KMTS
Kestra Medical Technologies, Ltd.
$29.69-3.01%
LEANNEUTRAL / wait for cleaner tape
WHY
- Kestra Medical Technologies, Ltd. (KMTS) is trading at $29.69, down 3.01% since the previous close and +3.23% over the past week. Price sits above its 50-day average by 11.23%, with price momentum at 76/100 and trend velocity at 67/100. Sentiment across 6 recent headlines reads net constructive at 58/100. Volatility risk is elevated (93/100) and the stock is 90% of the way up its 52-week range. The weighted factor score lands at 69/100 — a neutral signal. Research only, not investment advice.
- Bull input: Momentum 76/100 confirmed by trend velocity 67/100.
- Bear input: No bearish case in the sources.
RISK
Signals are model output from public data, not personalized investment advice.
INVALIDATE
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · Strong edge
live data
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
6 relevant headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
News Sentiment58/100
Price Momentum76/100
Trend Velocity67/100
Volatility Risk93/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
Signal Explanation
Kestra Medical Technologies, Ltd. (KMTS) is trading at $29.69, down 3.01% since the previous close and +3.23% over the past week. Price sits above its 50-day average by 11.23%, with price momentum at 76/100 and trend velocity at 67/100. Sentiment across 6 recent headlines reads net constructive at 58/100. Volatility risk is elevated (93/100) and the stock is 90% of the way up its 52-week range. The weighted factor score lands at 69/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on KMTS
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgeStrong edgeNeutral
Inputs: newsSentiment, dayChange
Sentiment 58/100 + price -3.0% are both mid-range.
Inputs: unusualVolume, dayChange
Volume read 16/100 with price drift -3.0% — no clear footprint.
Inputs: volatilityRisk, momentum
Vol regime 93/100 is too high to trust either direction without confirmation.
Inputs: pctOfRange, trendVelocity
Near range top — needs fresh catalyst to break out.
Inputs: newsSentiment, weekChange
Sentiment 58/100 vs week change 3.2% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price 11.2% over 50d SMA with momentum confirming — uptrend intact.
Inputs: momentum, trendVelocity
Oscillator at 72 — neutral zone.
Inputs: momentum, dayChange, vsSma50
Momentum 76/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 58/100 and weekly change 3.2% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 16/100 is quiet while trend velocity stays firm — supply looks thin.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 93/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Price is at a range extreme, but the tape is not confirming the breakout.
Inputs: newsSentiment, momentum, weekChange
Sentiment 58/100 and momentum 76/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
Price is above the 50d SMA and both momentum and trend velocity are holding up.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 72 does not show a rebound edge.
Why the ensemble agrees
- Vol regime 93/100 is too high to trust either direction without confirmation.
- Price is at a range extreme, but the tape is not confirming the breakout.
- Near range top — needs fresh catalyst to break out.
Counter-trees
- Momentum 76/100 confirmed by trend velocity 67/100.
- Price 11.2% over 50d SMA with momentum confirming — uptrend intact.
Bull Case
- Momentum 76/100 confirmed by trend velocity 67/100.
- Price 11.2% over 50d SMA with momentum confirming — uptrend intact.
- Volume 16/100 is quiet while trend velocity stays firm — supply looks thin.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Yahoo Finance55
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?
8/5/2026, 5:03:00 AM
Yahoo Finance60
Kestra Medical Technologies (KMTS): Assessing Valuation After Recent Surge in Share Price
10/10/2025, 8:11:00 AM
Investing.com India53
Kestra Medical Technologies Inc (KMTS)
10/23/2026, 12:59:00 PM
Nasdaq65
BTIG Initiates Coverage of Kestra Medical Technologies (KMTS) with Buy Recommendation
11/17/2025, 4:00:00 PM
MSN61
Analysts estimate Kestra Medical Technologies, Ltd. (KMTS) to report a decline in earnings: What to look out for
9/7/2026, 7:00:00 AM
Key stats
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Market cap
- $1.77B
- 52-week range
- $31.04/$17.34
- Volume
- 324,940
- Avg volume
- 379,183
- Analyst 1-yr target
- $30.00
- Exchange
- NASDAQ-GS
Source: Nasdaq public quote data. Research only.
Insider trades
0 buys · 4 sells by KMTS insiders (SEC Form 4 filings)
- SELL Umberger Traci S See Remarks · 2026-10-22$2.62M
- SELL Webster Brian Daniel See Remarks · 2026-10-22$393K
- SELL Umberger Traci S See Remarks · 2026-10-22$101K
- SELL Webster Brian Daniel See Remarks · 2026-10-22$50K
Earnings Intelligence
Next
Dec 10, 2026
Estimate
$-0.61
Actual
$-0.75
- • Last report Sep 14, 2026 (Jul 2026): EPS $-0.75 vs $-0.61 expected, -22.95% surprise.
- • Beat estimates in 0 of the last 4 quarters.
- • Next report expected Dec 10, 2026, consensus EPS $-0.61 (Zacks estimate via Nasdaq; the company may confirm a different date).
Risk Warnings
- • Signals are model output from public data, not personalized investment advice.
- • High volatility — position sizing and stops matter more here.
- • Confirm liquidity, spreads, and your own thesis before acting.
KMTS questions
What is the MarketPicks AI signal for Kestra Medical Technologies, Ltd. stock (KMTS)?
As of Nov 2, 12:04 AM ET, the ensemble reads neutral on KMTS — no consensus — 12 of 16 bots holding, with 4 bull, 0 bear and 12 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest KMTS price on MarketPicks?
KMTS was $29.69 on the latest quote (Nov 2, 12:04 AM ET), -3.01% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for KMTS mean?
Scores run from 0 to 100, with 50 neutral. KMTS shows momentum 76/100, trend velocity 67/100 and volatility risk 93/100, with news sentiment at 58/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.